Rocket Pharmaceuticals, Inc.

RCKTSTOCK

Hold

Score+0.841

About

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.

Sector: Health Technology
Industry: Biotechnology
Founded: 1999
IPO: 2015-02-18

rocketpharma.com

On this page

Rebuzz Analysis

Hold

Last updated Mar 27, 2026, 8:20 PM UTC

Rebuzz Score

+0.841

Strong Buy zone

SSSHBSB

-1.0-0.40.00.41.0

Score Breakdown

Market Price

Loading market data...

Signal History

Community

Communities

Total Mentions

High Authority

CommunityMentionsScoreSignal

r/pennystocksMed

30.700

Bullish

r/biotech_stocksMed

3-0.117

Lean Bear

r/TheRaceTo10MillionMed

20.900

Bullish

r/Stocks_PicksHigh

10.800

Bullish

r/investingMed

10.900

Bullish

About Rocket Pharmaceuticals, Inc.

Scroll here to load company intelligence.

News

Scroll here to load latest news and sentiment.